Exogene Raises $2 million for its AI platform to Discover Cell Therapies for Cancer
Oxford, UK, 25th April 2022 / Sciad Newswire / Exogene, a biotech
company discovering novel T-cell receptor-based cell therapies, today
announces that it has raised US$2 million in funding to develop its
artificial intelligence (AI) platform for T-cell receptor discovery.
More info >> |